TrialFinder  /  Landscape Report BIPOLAR DISORDER  ·  2026-09-02 Revasser  /  revasserkernel.com
Landscape Report TrialFinder
SOURCE  ClinicalTrials.gov API v2
GENERATED  2026-09-02
VERSION  v1
SAMPLE  100 of 4214 studies

bipolar disorder

The bipolar disorder clinical trial landscape includes 4214 actively recruiting trials. Semantic expansion identified 4006 additional trials beyond exact-match search, representing a 1926% discovery lift across related conditions and therapeutic approaches.

Recruiting
4214
active trials
Expansion Lift
+1926%
4006 additional trials
Top Sponsor
University Hospital, Antwerp
2 trials
Dominant Phase
NA
56 of 107 sampled
Pipeline Overview
Phase Distribution
NA
56
Early I
2
Phase 1
9
Phase 2
11
Phase 3
5
Phase 4
4
Other
20
Therapeutic Modalities
OTHER
53
DRUG
47
BEHAVIORAL
41
DEVICE
22
DIETARY_SUPPLEMENT
9
PROCEDURE
7
BIOLOGICAL
5
DIAGNOSTIC_TEST
3
Recruiting vs. Completed (2yr)
Recruiting
4214
Completed
2920
Competitive Landscape
Sponsor Classification
92%
4%
4%
OTHER (23)
INDUSTRY (1)
OTHER_GOV (1)
Top Sponsors
SponsorTrialsClass
University Hospital, Antwerp2OTHER
Stanford University2OTHER
Washington State University2OTHER
Hospices Civils de Lyon2OTHER
University of California, San Francisco2OTHER
Xuanwu Hospital, Beijing2OTHER
Massachusetts General Hospital2OTHER
Washington University School of Medicine2OTHER
University of Chicago2OTHER
University of Helsinki2OTHER
Nimbus Wadjet, Inc.1INDUSTRY
Zhujiang Hospital1OTHER
Universitätsklinikum Hamburg-Eppendorf1OTHER
Shanghai Changzheng Hospital1OTHER
Centre Hospitalier Charles Perrens, Bordeaux1OTHER_GOV
Geographic Distribution
Top U.S. States by Trial Density
StateTrialsTop City
Massachusetts18Boston
California16Palo Alto
New York12New York
Pennsylvania7Pittsburgh
Texas7Austin
Ohio5Cincinnati
Florida5Miami
Illinois4Chicago
Maryland4Bethesda
New Jersey4Cherry Hill
Alabama3Birmingham
Georgia3Atlanta
Michigan3Ann Arbor
North Carolina2Charlotte
Rhode Island2Providence
Virginia2Charlottesville
Arizona2Tucson
Nevada2Las Vegas
Oklahoma2Edmond
Oregon2Portland
Expansion Intelligence
+1926%
Discovery lift — trials found by semantic expansion that exact-match search misses entirely. This is the gap competitors don't see.
4
Exact
2
Parent
5
Related
5
Comorbid
6
Therapeutic
Top Expansion Terms
  • mood disorder Parent
  • affective disorder Parent
  • cyclothymia Related
  • schizoaffective disorder Related
  • mood episode Related
  • mania Related
  • hypomania Related
  • anxiety Comorbid
  • substance use disorder Comorbid
  • metabolic syndrome Comorbid

These terms are curated from clinical literature — not generated by a language model. Each captures trials that use variant nomenclature for the same underlying condition or therapeutic area.

Key Findings
What This Landscape Means for bipolar disorder
high
Standard searches miss 1926% of relevant trials for bipolar disorder — semantic expansion across related conditions and therapeutic approaches is essential for complete landscape visibility.
4006 additional trials found via expansion vs 208 exact matches
high
Phase 2 volume (11) significantly exceeds Phase 3 (5), indicating a pipeline bottleneck — most candidates are 2-4 years from potential approval.
Phase 2/Phase 3 ratio: 2.2x
Next Steps
Take Action on This Intelligence
//
Stay Current
Get alerted when new trials open for bipolar disorder and related conditions. Free tier monitors 1 condition weekly.
Set Up Alerts
[+]
Research Portal
Deploy this intelligence as your organization's permanent research hub — auto-updating, branded, zero hosting cost.
From $497
{<}
API Access
Integrate trial intelligence into your own tools. Full expansion engine, landscape analytics, real-time data.
View Plans
Top Recruiting Trials
20 actively recruiting studies
NCT06898450 PHASE1, PHASE2
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Nimbus Wadjet, Inc. n=134 USC Norris Comprehensive Cancer Center Los Angeles, California
Intervention DRUG: NDI-219216 — NDI-219216 is a highly selective small molecule inhibitor of WRN helicase activity.
Eligibility Ages 18 Years – 99 Years
Contact Sean Rossi · 857-600-8779 · sean.rossi@nimbustx.com
NCT07380113 PHASE4
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
Zhujiang Hospital n=50 Zhujiang Hospital, Southern Medical University, No. 253 Gongye Road, Guangzhou, 510282, China Guangzhou, Guangdong
Intervention DRUG: Anrikefon — intravenous administration
Eligibility Ages 18 Years – 75 Years
Contact Fengxian Li, DM · +86-20-62782857 · lifengxian81@smu.edu.cn
Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database
Universitätsklinikum Hamburg-Eppendorf n=500 University Medical Center Hamburg-Eppendorf Hamburg
Intervention OTHER: Natural History — Natural History and Clinical Follow Up.
Contact Miriam Nickel, MD · +4940741020440 · m.nickel@uke.de
Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome
Shanghai Changzheng Hospital n=161 Center for Reproductive Medicine,Shanghai Changzheng Hospital Shanghai, Shanghai Municipality
Intervention BIOLOGICAL: oral Fecal Microbiota Transplantation — Participants will receive standardized oral FMT freeze-dried powder capsules without antibiotic pretreatment. The capsul...
Eligibility Ages 20 Years – 40 Years, FEMALE only
Contact Ningxia Sun, Chief · 13817975897 · suesunchzh@126.com
Efficacy of a Smartphone App. Designed to Manage Craving & Individual Predictors of Substance Use/Addictive Behavior
Centre Hospitalier Charles Perrens, Bordeaux n=274 Centre Hospitalier Charles PERRENS Bordeaux
Intervention OTHER: Smartphone application — Ecological Momentary Assessment (EMA) : ambulatory assessment of behaviors/symptoms in real-time on smartphones
Eligibility Ages 18 Years
Contact MARC AURIACOMBE, MD, Prof · 05 56 56 17 38 · mauriacombe@ch-perrens.fr
Lifestyle Interventions to Prevent Cognitive Deficits in Subjects With Depressive Symptoms: From Mechanisms to Clinical Practice
IRCCS Centro San Giovanni di Dio Fatebenefratelli n=120 IRCCS Centro San Giovanni di Dio Fatebenefratelli Brescia
Intervention BEHAVIORAL: Mediterranean Diet — Participants will receive only the educational intervention about the Mediterranean diet. The program consists of 4-5 on...
Eligibility Ages 50 Years – 80 Years
Contact Elisa Mombelli · (+39) 030 35 01 598 · emombelli@fatebenefratelli.eu
Pathophysiological Endotyping Using Baseline Polysomnography Data
University Hospital, Antwerp n=1000 Antwerp University Hospital Edegem
Intervention PROCEDURE: Drug-induced sleep endoscopy — Endoscopy during drug-induced sleep
Eligibility Ages 18 Years
Contact Sara Op de Beeck, PhD · 0032 3 821 3385 · sara.opdebeeck@uza.be
Comfort Intervention in PICU Children
Ankara Yildirim Beyazıt University n=86 Ordu Universitesi Egitim ve Arastirma Hastanesi Ordu, Altınordu
Intervention BEHAVIORAL: Intervention Family-Centered Comfort — Storytelling with the mother's voice, dimmed lighting, and weighted blanket administered by the researcher to children i...
Eligibility Ages 5 Years – 10 Years
NCT01406691 PHASE4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Stanford University n=20 Stanford University Palo Alto, California
Intervention DEVICE: Flashes — one hour of a sequence of light flashes (4000 lux, 3 msec, every 30 seconds); occurs during the hour immediately prior t...
Eligibility Ages 15 Years – 19 Years
Contact Jamie Zeitzer, PhD · 650-493-5000 · jzeitzer@stanford.edu
Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery
Washington State University n=30 Washington State University Research Clinic Spokane, Washington
Eligibility Ages 18 Years – 35 Years
Contact Alex Schmidt · 509-638-2376 · alex.schmidt@wsu.edu
Triage Survey for Psychiatry Research Eligibility
Adams Clinical n=20000 Adams Clinical, Boston Boston, Massachusetts
Intervention OTHER: Survey — Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine dru...
Eligibility Ages 18 Years
Contact Miriam Evans, PhD · 617-744-8542 · mevans@adamsclinical.com
Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis
Mitral n=500 Centre de pneumologie et sommeil Aix-en-Provence
Intervention DEVICE: Apneal device — Patients will wear a smartphone with the Apneal Application on their chest, while they perform polysomnography
Eligibility Ages 18 Years
Contact Guillaume Cathelain, PhD · +33672448711 · guillaume.cathelain@apneal.ai
Sleep and Rehearsal-Driven Memory in Epilepsy
Hospices Civils de Lyon n=20 Service de neurologie fonctionnelle et d'épileptologie, Hôpital neurologique Pierre Wertheimer Bron
Intervention OTHER: Cognitive memory task on a computer — Encoding: (1) Participants will learn 60 associations between pairs of items (cue and target) that are presented sequent...
Eligibility Ages 18 Years – 65 Years
Contact Laure PETER-DEREX, Professor · +334 72 07 17 69 · laure.peter-derex@chu-lyon.fr
Pilot Project on Interdisciplinary Therapy of Obesity
University of Hohenheim n=480 University of Heidelberg Heidelberg
Intervention PROCEDURE: Laparoscopic gastric sleeve — Laparoscopic gastric sleeve
Eligibility Ages 18 Years – 65 Years
Contact Antje Damms-Machado, Dipl. troph. · +49 711 451017707 · antje.machado@uni-hohenheim.de
Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial
Sir Run Run Shaw Hospital n=2000 Sir Run Run Shaw Hospital Hangzhou
Intervention OTHER: cognitive behaviour thearpy — Participants will access the CBT text materials through a dedicated platform
Eligibility Ages 18 Years – 65 Years
Contact Yanhui Liao · 86 18814898844 · liaoyanhui@zju.edu.cn
Effectiveness of CAT-GSH for Returning Patients
University of Sheffield n=100 Tameside and Glossop NHS Talking Therapies Service Ashton-under-Lyne
Intervention BEHAVIORAL: Cognitive analytic therapy guided self-help (CAT-GSH) — Six session CAT-GSH treatment
Eligibility Ages 16 Years
Contact Andrew J Laphan · 01142226650 · alaphan1@sheffield.ac.uk
NCT06074250 PHASE2, PHASE3
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
The Canadian College of Naturopathic Medicine n=100 Sunnybrook Health Science Center Toronto, Ontario
Intervention DIETARY_SUPPLEMENT: Fish oil — 1500mg EPA +1000mg DHA daily
Eligibility Ages 18 Years – 43 Years, FEMALE only
Contact Neda Ebrahimi, PhD · 416-498-1255 · nebrahimi@ccnm.edu
BioClock: Bright Light Therapy for Depressive Disorders
Universiteit Leiden n=231 GGzE - Mental Health Institute of Eindhoven and the Kempen Eindhoven
Intervention PROCEDURE: Bright Light Therapy — In this study, Bright Light Therapy (BLT) will be administered according to Dutch depression guidelines, using Innolux L...
Eligibility Ages 18 Years – 65 Years
Contact Niki Antypa, PhD · +31 71 527 6677 · nantypa@fsw.leidenuniv.nl
Preoperative Sleep Quality and Postoperative Outcomes in Breast Surgery
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital n=150 Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea Ankara, Yenimahalle
Intervention OTHER: Preoperative Sleep Quality Assessment (PSQI) — Preoperative sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI), a validated self-reported q...
Eligibility Ages 18 Years – 70 Years, FEMALE only
Contact Mustafa Kemal Şahin · +905075800976 · mksahin@msn.com
Efficacy of Written Versus Video Patient Education Materials for Postmastectomy Breast Reconstruction
University of California, San Francisco n=100 University of California, San Francisco San Francisco, California
Intervention OTHER: Questionnaires — Participants will complete health related questionnaires.
Eligibility Ages 18 Years
Contact Reta Behman, BA · 877-827-3222 · Reta.Behman@ucsf.edu